Stock overview
Neurocrine Biosciences Inc.
Explore the company, reported ownership, price history, and available source evidence.
NEUROCRINE BIOSCIENCES INC (NBIX) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $162.86
- · NBIX
- Tracked holders
- 4 funds
- Latest available 13F per fund
NBIX · USD
Price
Close · Nov 18, 2026
- Range low
- $123.10
- Range high
- $185.50
- Observations
- 252
- Session date
- Nov 18, 2026
Nov 18, 2025–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Renaissance Technologies largest tracked holder Q3 2026 · filed Nov 12, 2026 · SEC filing | −2% 26'Q3 | $326,330,862 | 0.44% |
| Gotham Asset Management position history Q3 2026 · filed Nov 16, 2026 · SEC filing | −15% 26'Q3 | $44,803,994 | 0.09% |
|
Thrive Capital
position history
Q2 2026
· filed Aug 14, 2026
· SEC filing 1 SEC filing 2 |
−2% 26'Q2 | $4,622,579 | 0.11% |
| Polen Capital Management position history Q3 2026 · filed Nov 13, 2026 · SEC filing | Newly reported 26'Q3 | $226,235 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market